Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of preparation method of pralatrexate intermediate

A technology of pralatrexate and intermediates, applied in the field of medicine, can solve the problems of low yield, long reaction time, low yield and purity, etc., to improve yield and purity, simplify post-treatment process, and improve operability sexual effect

Active Publication Date: 2021-06-04
SHANDONG NEWTIME PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are many problems in the existing synthesis technology: when synthesizing the intermediate (PLQS-2), a mixture of monopropargyl and bispropargyl (impurity) is produced, that is, the intermediate containing 1 / 3 to 1 / 2 of the impurity (PLQS-2) (“J.Med.Chem.1993,36,2228-2231” Joseph I.De Graw; J William T.Colwell), the yield and purity of (PLQS-2) were low, and the impurities The production situation is shown in the following reaction equation:
[0007] US0183789A1 introduces the use of potassium carbonate as a nucleophile and TBAI as a phase transfer catalyst at 25-30°C for 20-26 hours. Through liquid phase detection, the ratio of the target product to the bispropargyl-substituted impurity is 85:15, and after two The refined purity reaches 99.2%. Although the reaction temperature of this technical method is mild, the reaction time is long, and the generated bispropargyl substitutes more impurities, which requires two refinements, and the yield is low, which is 65.6%.
[0008] This brings difficulties to the next reaction and post-processing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of pralatrexate intermediate
  • A kind of preparation method of pralatrexate intermediate
  • A kind of preparation method of pralatrexate intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Under the protection of argon, add 323g PLQS-1 and 2.26L THF into a 5L three-necked flask, and when the temperature is lowered and stirred to -10°C, pour 224ml of 3-bromopropyne into the reaction flask, keep stirring for 0.5h, and start to drop 1.8L THF solution of 1mol / L LiHMDS, control the dropping rate, and keep the reaction temperature at -10±3°C (about 2 to 3 hours to complete the dropping). After the dropwise addition, continue to stir for 0.5 h, and detect by HPLC. After the reaction is complete, pour the reaction liquid into 1.25 L of acetic acid aqueous solution, stir for 10 min, and then let stand to separate the liquids. Add about 1.3L of isopropanol, stir to precipitate a solid, then put it in a cold bath at 0-5°C, stir for 3-4h, filter, and wash with a mixed solvent of about 300ml of isopropanol: n-heptane = 1:6 filter cake. The filter cake was oven-dried at 50°C to finally obtain 332g of light yellow solid with a yield of 87.0%. The HPLC detection of the ...

Embodiment 2

[0028] Under the protection of argon, add 323g PLQS-1 and 2.26L THF into a 5L three-necked flask, cool down and stir to -20°C, pour 224ml 3-bromopropyne into the reaction flask, keep stirring for 0.5h, and start to drop 1.8L 1mol / L. THF solution of LiHMDS, control the rate of addition, and keep the reaction temperature at -20±3°C (about 2 to 3 hours to complete the drop). After the dropwise addition, continue to stir for 0.5 h, and detect by HPLC. After the reaction is complete, pour the reaction liquid into 1.25 L of acetic acid aqueous solution, stir for 10 min, and then let stand to separate the liquids. Add about 1.3L of isopropanol, stir to precipitate a solid, then put it in a cold bath at 0-5°C, stir for 3-4h, filter, and wash with a mixed solvent of about 300ml of isopropanol: n-heptane = 1:6 filter cake. Filter cake is oven-dried at 50 ℃, finally obtains 320g light yellow solid, yield is 83.8%, the HPLC detection of intermediate α-propargyl-(4-formic acid methyl este...

Embodiment 3

[0030] Under the protection of argon, add 323g PLQS-1 and 2.26L ethyl acetate into a 5L three-necked flask, cool down and stir to -10°C, pour 224ml 3-bromopropyne into the reaction flask, keep stirring for 0.5h, start Add 1.8L of 1mol / L.LiHMDS THF solution dropwise, control the dropping rate, and keep the temperature of the reaction bottle at -10±3°C (about 2 to 3 hours to complete the dropping). After the dropwise addition, continue to stir for 0.5 h, and detect by HPLC. After the reaction is complete, pour the reaction liquid into 1.25 L of acetic acid aqueous solution, stir for 10 min, and then let stand to separate the liquids. Add about 1.3L of isopropanol, stir to precipitate a solid, then put it in a cold bath at 0-5°C, stir for 3-4h, filter, and wash with a mixed solvent of about 300ml of isopropanol: n-heptane = 1:6 filter cake. Filter cake is oven-dried at 50 ℃, finally obtains 330g light yellow solid, yield is 86.4%, the HPLC detection of intermediate α-propargyl-(...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and in particular relates to a preparation method of a pralatrexate intermediate. The invention provides a method for preparing an intermediate α-propargyl-(4-methyl formate)-methyl phenylacetate with simpler operation and lower impurity content, especially the proportion of bispropargyl impurities generated in the product Obviously reduce, the yield of the target product α-propargyl-(4-methyl formate)-methyl phenylacetate of generation obviously increases, and the purity of product improves greatly, can be applied to large-scale production of pralatrexate bulk drug and The preparation of its intermediates.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a preparation method of a pralatrexate intermediate. Background technique [0002] Pralatrexate, trade name Folotyn, is the first new targeted folic acid preparation approved by the FDA for the treatment of peripheral T-cell lymphoma. The chemical name of pralatrexate is 10-propargyl-10-desazaaminopterin. First disclosed in "Synthesis and Antitumor Activity of 10-Propargyl-10-deazaaminopterin" J.Medical Chem.36:2228-2231 (1993) by Joseph I. DeGraw; J William T. Colwell et al. It was then studied by Sirotanak et al and O'Connor et al. Its molecular structure is as follows: [0003] [0004] Pralatrexate is synthesized from p-carboxyphenylacetic acid as a starting material through a series of chemical transformations. First, the intermediate 4-methyl formate, methyl phenylacetate (PLQS-1), the intermediate α-propargyl-(4-methyl formate)-methyl phenylacetate (PLQ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C67/343C07C69/76
CPCC07C67/343C07C69/76
Inventor 张贵民陈成富魏传兵
Owner SHANDONG NEWTIME PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products